Approaches to improve metabolic stability of a statine-based GRP receptor antagonist-Reference-Cited by-同舟云学术

Approaches to improve metabolic stability of a statine-based GRP receptor antagonist

Published:2017-02 Issue: Volume:45 Page:22-29
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Popp Ilinca,Del Pozzo Luigi,Waser Beatrice,Reubi Jean Claude,Meyer Philipp T.,Maecke Helmut R.,Gourni Eleni

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference40 articles.

1. Nuclear imaging probes: from bench to bedside;Wester;Clin Cancer Res,2007

2. Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-TYR6, ß-ALA11, PHE13, NLE14] bombesin (6-14);Reubi;Clin Cancer Res,2002

3. Gastrin-releasing peptide receptors in the human prostate relation to neoplastic transformation;Markwalder;Cancer Res,1999

4. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast;Gugger;Am J Pathol,1999

5. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers;Sun;Regul Pept,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Radiolabeled Peptide Radiopharmaceuticals;Molecular Imaging and Targeted Therapy;2023

2. Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence;Pharmaceuticals;2022-09-10

3. Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in ¹⁷⁷Lu-RM2 Results in ¹⁷⁷Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability;Journal of Nuclear Medicine;2022-01-13

4. Radiolabeled Bombesin Analogs;Cancers;2021-11-17

5. 68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2;Pharmaceutics;2021-07-28